Cns Pharmaceuticals Inc Stock
Cns Pharmaceuticals Inc Stock price
Key metrics
| Market capitalization | $3.68m |
| Enterprise Value | $-2.45m |
| P/E (TTM) P/E ratio | 0.00 |
| EV/FCF (TTM) EV/FCF | 0.14 |
| P/B ratio (TTM) P/B ratio | 0.29 |
| Revenue (TTM) Revenue | $0.00 |
| EBIT (operating result TTM) EBIT | $-14.90m |
| Free Cash Flow (TTM) Free Cash Flow | $-17.12m |
| Cash position | $6.46m |
Is Cns Pharmaceuticals Inc a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?
As a Free StocksGuide user, you can view scores for all 6,794 stocks worldwide.
Cns Pharmaceuticals Inc Stock Analysis
Analyst Opinions
2 Analysts have issued a Cns Pharmaceuticals Inc forecast:
Analyst Opinions
2 Analysts have issued a Cns Pharmaceuticals Inc forecast:
Financial data from Cns Pharmaceuticals Inc
| Dec '24 |
+/-
%
|
||
| Revenue | - - |
-
|
|
| Gross Profit | - - |
-
|
|
| EBITDA | -15 -15 |
21%
21%
|
EBIT (Operating Income) EBIT | -15 -15 |
21%
21%
|
| Net Profit | -15 -15 |
21%
21%
|
|
In millions USD.
Don't miss a Thing! We will send you all news about Cns Pharmaceuticals Inc directly to your mailbox free of charge.
If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.
Cns Pharmaceuticals Inc Stock News
Company Profile
CNS Pharmaceuticals, Inc., a preclinical stage pharmaceutical company, focuses on the development of anti-cancer drug candidates for the treatment of primary and metastatic brain, and central nervous system tumors. The company's lead drug candidate is Berubicin, which completed Phase I clinical trial that is used for the treatment of glioblastoma. It has a development agreement with WPD Pharmaceuticals Inc. for the development of several preclinical drug candidates including WP1122, which will be tested on a range of viruses, including the coronavirus SARS-CoV-2. CNS Pharmaceuticals, Inc. was founded in 2017 and is based in Houston, Texas.
| Head office | United States |
| CEO | John Climaco |
| Employees | 5 |
| Founded | 2017 |
| Website | www.cnspharma.com |
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
